(19)
(11) EP 1 204 657 A1

(12)

(43) Date of publication:
15.05.2002 Bulletin 2002/20

(21) Application number: 00957534.1

(22) Date of filing: 18.08.2000
(51) International Patent Classification (IPC)7C07D 401/12, C07D 207/08, C07D 401/06, C07D 401/14, C07D 207/09, C07D 213/38, A61K 31/4409, A61K 31/4439, A61K 31/40, A61P 25/28
(86) International application number:
PCT/US0022/617
(87) International publication number:
WO 0112/622 (22.02.2001 Gazette 2001/08)
(84) Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
Designated Extension States:
AL LT LV MK RO SI

(30) Priority: 18.08.1999 DE 19939707
25.08.1999 US 150568 P

(71) Applicants:
  • SCHERING AKTIENGESELLSCHAFT
    13342 Berlin (DE)
  • VERTEX PHARMACEUTICALS INCORPORATED
    Cambridge, MA 02139-4242 (US)

(72) Inventors:
  • BRUMBY, Thomas
    D-12163 Berlin (DE)
  • MCDONALD, Fiona
    D-14055 Berlin (DE)
  • SCHNEIDER, Herbert
    D-10707 Berlin (DE)

(74) Representative: Pohlman, Sandra M. et al
Dörries Frank-Molnia & Pohlman,Triftstrasse 13
80538 München
80538 München (DE)

   


(54) PIPERIDINE AND PYRROLIDINE DERIVATIVES DISPLAYING NEURONAL ACTIVITY